Wenjun Yi

1.8k citations

94 papers · 1.1k indexed · h-index 20

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
Oncology top 10%

Papers in ⓘ

Cancer Research 24
- Breast Cancer Treatment Studies 9
- Cancer, Hypoxia, and Metabolism 5
Oncology 24
- Cancer Immunotherapy and Biomarkers 6

Co-authors: Qiongyan Zou (27 shared papers)Enxiang Zhou (6 shared papers)Feng Xu (4 shared papers)Jia Yao (2 shared papers)Danhua Zhang (3 shared papers)Qitong Chen (19 shared papers)Dengjie Ouyang (11 shared papers)Lei Pei (4 shared papers)
Journals: Scientific Reports (5 papers)Frontiers in Immunology (4 papers)European Polymer Journal (3 papers)Journal of Cellular Biochemistry (2 papers)Journal of Polymer Research (2 papers)
Partner nations: China United States Japan

In The Last Decade

Wenjun Yi

80 papers receiving 1.1k citations

Peers

Countries citing papers authored by Wenjun Yi

Since Specialization

Citations

This map shows the geographic impact of Wenjun Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Yi more than expected).

Fields of papers citing papers by Wenjun Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Yi. The network helps show where Wenjun Yi may publish in the future.

Co-authors

The 25 scholars most cited alongside Wenjun Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenjun Yi Line = papers co-authored together Wenjun Yi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Molecular Endocrinology ·Wenjun Yi, S O Kim, Jing Jiang, SungJi Park, Andrew S. Kraft, David J. Waxman, Stuart J. Frank	1996	82
2	Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway Cell Death and Disease ·Qipan Deng, Xinfang Yu, Lanbo Xiao, Zhilan Hu, Xiangjian Luo, Yongguang Tao, Lifang Yang, Xiaowen Liu, H Chen, Zhihui Ding, Tao Feng, Yuchen Tang, Xisheng Weng, Jian Guo Gao, Wenjun Yi, Ann M. Bode, Zigang Dong, Jiangying Liu, Ya Cao	2013	66
3	A TP73‐AS1/miR‐200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration Journal of Cellular Biochemistry ·Qiongyan Zou, Enxiang Zhou, Feng Xu, Danhua Zhang, Wenjun Yi, Jia Yao	2017	63
4	TP73‐AS1 promotes breast cancer cell proliferation through miR‐200a‐mediated TFAM inhibition Journal of Cellular Biochemistry ·Jia Yao, Feng Xu, Danhua Zhang, Wenjun Yi, Xianyu Chen, Gannong Chen, Enxiang Zhou	2017	60
5	Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients Breast Cancer Research and Treatment ·Zibo Li, Xinwu Guo, Yepeng Wu, Shengyun Li, Jinhua Yan, Limin Peng, Zhi Xiao, Shouman Wang, Zhongping Deng, Lizhong Dai, Wenjun Yi, Kun Xia, Lili Tang, Jun Wang	2015	49
6	Targeting lncRNA DDIT4‐AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy Advanced Science ·Ting Jiang, Jiaojiao Zhu, Shilong Jiang, Zonglin Chen, Ping Xu, Rong Gong, Changxin Zhong, Yueying Cheng, Yueying Cheng, Xinyuan Sun, Wenjun Yi, Jinming Yang, Wenhu Zhou, Yan Cheng	2023	48
7	Distribution of HLA‐A, ‐B, ‐Cw, and ‐DRB1 alleles and haplotypes in an isolated Han population in Southwest China Tissue Antigens ·Yufeng Yao, Li Shi, Masaki Matsushita, Liang Yu, Kuang Lin, Ya‐Xiong Tao, Xiaoyi Huang, Wenjun Yi, Toshihiko Oka, Katsushi Tokunaga, Jiayou Chu	2009	43
8	Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer Molecular Imaging ·Jun He, Leping Yang, Wenjun Yi, Wentao Fan, Yu Wen, Xiongying Miao, Li Xiong	2017	41
9	RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2 Archives of Biochemistry and Biophysics ·Qiongyan Zou, Haijun Wu, Fenfen Fu, Wenjun Yi, Lei Pei, Meirong Zhou	2016	40
10	A literature review of the promising future of TROP2: a potential drug therapy target Annals of Translational Medicine ·Ying Wen, Dengjie Ouyang, Qiongyan Zou, Qitong Chen, Na Luo, Hongye He, Munawar Anwar, Wenjun Yi	2022	40
11	Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells Cell Communication and Signaling ·Peng Huang, Dengjie Ouyang, Shi Chang, Moyun Li, Lun Li, Qian-ying Li, Rong Zeng, Qiongyan Zou, Juan Su, Piao Zhao, Lei Pei, Wenjun Yi	2018	36
12	The Expression, Functions, Interactions and Prognostic Values of PTPRZ1: A Review and Bioinformatic Analysis Journal of Cancer ·Zhenkun Xia, Dengjie Ouyang, Qianying Li, Moyun Li, Qiongyan Zou, Lun Li, Wenjun Yi, Enxiang Zhou	2019	35
13	Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis Future Oncology ·Lun Li, Dongdong Han, Xiaowei Wang, Quan Wang, Jinhui Tian, Jia Yao, Liqin Yuan, Ke Qian, Qiongyan Zou, Wenjun Yi, Enxiang Zhou, Kehu Yang	2017	35
14	eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma Journal for ImmunoTherapy of Cancer ·Xisha Chen, Kuansong Wang, Shilong Jiang, Hongyin Sun, Xuanling Che, Minghui Zhang, Jiaying He, Ying Wen, Mengting Liao, Xiangling Li, Xiaoming Zhou, Jianxun Song, Xingcong Ren, Wenjun Yi, Jinming Yang, Xiang Chen, Mingzhu Yin, Yan Cheng	2022	31
15	Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing Journal of Cancer Research and Clinical Oncology ·Guoli Li, Xinwu Guo, Lili Tang, Ming Chen, Xipeng Luo, Limin Peng, Xunxun Xu, Shouman Wang, Zhi Xiao, Wenjun Yi, Lizhong Dai, Jun Wang	2017	30
16	Autoantibodies as biomarkers for breast cancer diagnosis and prognosis Frontiers in Immunology ·Ruozhu Yang, Yi Han, Wenjun Yi, Long Qian	2022	25
17	A novel role of kynureninase in the growth control of breast cancer cells and its relationships with breast cancer Journal of Cellular and Molecular Medicine ·Yingzhe Liu, Xueping Feng, Jinping Lai, Wenjun Yi, Jiu Yang, Tao Du, Xueying Long, Ye Zhang, Yongzhi Xiao	2019	23
18	Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer BMC Cancer ·Zhongzhi Wang, Limeng Qu, Qitong Chen, Yong Zhou, Hongtao Duan, Baifeng Li, Yao Weng, Juan Su, Wenjun Yi	2023	22
19	Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer Cell Communication and Signaling ·Ruozhu Yang, Yi Han, Xinyu Guan, Yue Hong, Jiahao Meng, Shirong Ding, Long Qian, Wenjun Yi	2023	22
20	Genetic link among Hani, Bulang and other Southeast Asian populations: evidence from HLA ‐A, ‐B, ‐C, ‐DRB1 genes and haplotypes distribution International Journal of Immunogenetics ·Lei Shi, Yufeng Yao, Michio M. Matsushita, Liang Yu, Xiaoyi Huang, Wenjun Yi, Toshihiko Oka, Katsushi Tokunaga, Jiayou Chu	2010	21

About Wenjun Yi

Wenjun Yi is a scholar working on Cancer Research, Oncology, Biotechnology, Pathology and Forensic Medicine and Molecular Biology, having authored 94 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Epigenetics and DNA Methylation (8 papers), Breast Lesions and Carcinomas (8 papers), Advanced Polymer Synthesis and Characterization (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (402 citations), Oncology (268 citations), Molecular Biology (556 citations), Immunology (131 citations) and Endocrinology, Diabetes and Metabolism (95 citations). Wenjun Yi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qiongyan Zou, Enxiang Zhou, Feng Xu, Jia Yao, Danhua Zhang, Qitong Chen, Dengjie Ouyang, Lei Pei, Jing Jiang and Andrew S. Kraft. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, European Polymer Journal, Journal of Cellular Biochemistry and Journal of Polymer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact